Quidel diagnostic gives quick COVID19 results but it’s less than perfect
Published on: May 13, 2020
The FDA gave emergency use authorization (EUA) late Friday to the first SARS-CoV-2 antigen test, which provides results indicating active infection in 15 minutes. It’s less sensitive than the current PCR-based molecular tests, however, and comes with important limits on its use.
